Skip to main content
. 2016 Feb 4;20(5):842–854. doi: 10.1111/jcmm.12768

Figure 6.

Figure 6

PAX5 inhibited the tumorigenicity of NSCLC in vivo. (A) Representative images of tumour growth in nude mice. (B) Growth curve for the PAX5‐expressing tumour compared to the control in nude mice. *P < 0.05, **P < 0.01. (C) Tumour weigh of PAX5‐expressing cells in nude mice compared with control tumours, *P < 0.05. (D) Representative photographs of HE staining and IHC analyses of the expression of PAX5 and Ki67 in tumours from nude mice (magnification, ×400). (E) Protein expression of PAX5 in both neoplasms from mouse #3. GAPDH was used as a control.